Imizol injectable 10ml

Composition of IMIZOL Injectable 10ml

IMIZOL Injectable 10ml contains imidocarb dipropionate as its active ingredient, a carbanilidic compound with specific antiparasitic action against protozoa of the genus Babesia and other hemoprotozoa such as Theileria and Anaplasma. This formulation is designed for use in veterinary medicine, particularly in dogs and equines.

Therapeutic indications

IMIZOL is indicated for the treatment of piroplasmosis (also known as babesiosis) in dogs and horses. This tick-borne disease affects red blood cells and can cause anemia, fever, lethargy, and, in severe cases, death. Imidocarb dipropionate works by interfering with the protozoan's metabolism, blocking its development and facilitating its elimination from the animal's body.

target species

This veterinary medicinal product is formulated for administration to dogs and equines. Its efficacy has been proven in both domestic animals and working and competition horses.

Route of administration and dosage

IMIZOL Injectable 10ml is administered intramuscularly or subcutaneously, depending on the species and the veterinarian's judgment. It is essential to adhere to the manufacturer's recommended dosage to avoid adverse reactions and ensure the treatment's effectiveness.

Cautions and warnings

• Do not administer to animals with known hypersensitivity to imidocarb.
• Avoid use in debilitated animals or those with hepatic or renal insufficiency without prior evaluation.
• The injection site should be rotated to avoid local reactions.
• It may cause side effects such as salivation, nausea, or mild cholinergic signs in some cases.

Interactions with other medications

Imidocarb dipropionate may potentiate the effects of cholinergic medications. Caution is advised when administered concomitantly with other drugs that affect the autonomic nervous system.

Storage

Store in a dry place below 25°C and protect from direct sunlight. Keep out of reach of children and untreated animals.

Frequently asked questions about IMIZOL Injectable 10ml

• What protozoa does IMIZOL Injectable 10ml combat?
  IMIZOL is effective against Babesia spp., Theileria spp. and Anaplasma spp., agents that cause piroplasmosis and anaplasmosis in dogs and equines.
• How long does it take for IMIZOL to take effect?
  Clinical signs usually improve within 24 to 72 hours after administration, depending on the animal's overall condition and parasite load.
• Can I use IMIZOL as a preventative treatment?
  Although its main use is therapeutic, in some cases it has been used for prophylactic purposes in endemic areas, under professional supervision.
• What precautions should I take after administration?
  It is recommended to observe the animal during the first few hours after the injection to detect possible adverse reactions such as excessive salivation or vomiting.
• Can IMIZOL be used on puppies or foals?
  Use in young animals should be carefully evaluated by a professional, considering the animal's weight, immune status, and general condition.
• What are the most common side effects?
  The most common adverse effects include salivation, mild vomiting, tremors, and, rarely, allergic reactions at the injection site.
• How should I store IMIZOL once opened?
  Once opened, it is recommended to use the contents as soon as possible and keep the vial tightly closed at a controlled temperature.
• What are the signs of babesiosis in dogs and horses?
  Signs include fever, pale mucous membranes, dark urine, weakness, loss of appetite, and in severe cases, collapse or sudden death if not treated promptly.